New U.S. trade deal may bring higher drug prices to U.K.

Bloomberg

13 July 2018 - UK will have less bargaining leverage once outside the EU.

U.K. politicians under pressure to clinch a new trade agreement with the US could compromise on the way their country regulates medicines, making prescription drugs more expensive after Brexit, three researchers wrote.

Under President Donald Trump, “American drug pricing policy now has the explicit and unusual goal of making drugs more expensive in other countries,” Holly Jarman, an assistant professor at the University of Michigan’s School of Public Health, and two England-based colleagues said in an article published in the Lancet medical journal on Thursday.

Read Bloomberg article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

England , Medicine , Pricing